Do you recommend the use of Korlym (Mifepristone) for patients with difficult to control diabetes and evidence of mild endogenous hypercortisolism of unknown source?

Do you recommend the use of Korlym (Mifepristone) for patients with difficult to control diabetes and evidence of mild endogenous hypercortisolism of unknown source?

• Yes, regardless of the degree of hypercortisolism or hyperglycemia
• No, only in severe hypercortisolism and hyperglycemia
• No, there is not enough data at present to support its use in such patients.
• Other